OM1 Launches MS Registry for Use in Research, Trial Planning

OM1 Launches MS Registry for Use in Research, Trial Planning

299638

OM1 Launches MS Registry for Use in Research, Trial Planning

OM1, a technology company focused on chronic conditions, announced that it has launched a multiple sclerosis (MS) registry to generate data that may ultimately be used to improve care and develop treatments for the disease. The OM1 registry is being touted as the largest, most representative MS data registry available for analytics, licensing, and collaboration. Registries typically use observational study methods to collect data that can be used to measure certain outcomes for a particular…

You must be logged in to read/download the full post.